Tag: Cancer: Leukemia

Survival for adolescent and young adult leukemia survivors remained below general population at up to 30 years of follow-up

CoVac-1, a peptide vaccine, induces T-cell immune responses in those with B-cell deficiencies, particularly leukemia and lymphoma patients

Event-free survival significantly longer compared with placebo and azacitidine for newly diagnosed IDH1-mutated AML

Mechanisms of resistance detectable prior to treatment and include hypermethylation of PCR2 targets in embryonic and cancer stem cells

CAR T cells detectable more than 10 years after infusion with sustained remission in both patients

Polygenic score based on single nucleotide polymorphisms in the ara-C pathway genes may predict treatment outcomes

Novel prognostic index CLL-WONT identifies patients with chronic lymphocytic leukemia who are at low risk for ever requiring treatment

However, nonlinear association seen between night shifts and chronic lymphocytic leukemia

Life challenges more negatively impacted in younger, female, relapsed patients; socializing more positively impacted in older patients

Incidence higher for men versus women, adults older than 70 years, and individuals living in high social-demographic index regions